Sort
50,496 grants matching “lung cancer”
Clinical Protocol and Data Management
$475,992Susanne M Arnold · University Of Kentucky · P30 · FY2025 · CA
Neutrophil Plasticity and H. pylori Pathogenesis
$475,904Lee-Ann H. Allen · University Of Iowa · R01 · FY2017 · AI
Neutrophil Plasticity and H. pylori Pathogenesis
$475,904Lee-Ann H. Allen · University Of Iowa · R01 · FY2019 · AI
Novel roles of STAT2 and IFN-I in tumorigenesis and responses to therapy
$475,893George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2023 · CA
MOLECULAR BIOLOGY OF JAAGSIEKTE SHEEP RETROVIRUS
$475,855University Of California Irvine · R01 · FY2003 · CA
Roles and regulation of transcriptional reprogramming in squamous carcinogenesis
$475,853Markus Schober · New York University School Of Medicine · R01 · FY2023 · CA
Clinical production of viral vectors for cancer gene therapy
$475,840Steven Feldman · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy
$475,810Steven A Belinsky · Lovelace Biomedical Research Institute · R01 · FY2021 · CA
Targeting DNA repair in KRAS mutated lung cancer by chemical screening
$475,767You-Wei Zhang · Case Western Reserve University · R01 · FY2022 · CA
Targeting DNA repair in KRAS mutated lung cancer by chemical screening
$475,767You-Wei Zhang · Case Western Reserve University · R01 · FY2023 · CA
Project 1: Delta immune Ecology of NSCLC
$475,697Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2024 · CA
Phenotypic Assay Design and Development for Rare and Neglected Diseases
$475,656James Inglese · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
Race,Treatment and Endometrial Cancer Survival
$475,581University Of Pennsylvania · R01 · FY2004 · CA
Chemoprevention of lung carcinogenesis using green tea
$475,566Iman A Hakim · University Of Arizona · U01 · FY2006 · CA
Cancer Vaccines and Modulation of Checkpoint Controls in Immunization
$475,552John Janik · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Mode of Action of the Amaryllidaceae Alkaloid Lycorine-Promising Anticancer Agent
$475,519Alexander Kornienko · Texas State University · R15 · FY2014 · CA
Mechanism and approach to inactivate mutant KRAS of lung metastatic colon cancer by RNA-ligand-displaying exosome to co-deliver dCas9--gRNA ribonucleoprotein complex and KRAS siRNA
$475,445Peixuan Guo · Ohio State University · R01 · FY2025 · CA
Targeting Acetyl-CoA Metabolism for the Discovery of New Anti-Cancer Therapeutics
$475,351Steven L McKnight · Ut Southwestern Medical Center · R01 · FY2014 · CA
Targeting Acetyl-CoA Metabolism for the Discovery of New Anti-Cancer Therapeutics
$475,351Steven L McKnight · Ut Southwestern Medical Center · R01 · FY2016 · CA
Targeting Acetyl-CoA Metabolism for the Discovery of New Anti-Cancer Therapeutics
$475,351Steven L McKnight · Ut Southwestern Medical Center · R01 · FY2017 · CA
Targeting Acetyl-CoA Metabolism for the Discovery of New Anti-Cancer Therapeutics
$475,351Steven L McKnight · Ut Southwestern Medical Center · R01 · FY2015 · CA
Improving The Quality Of Advanced Cancer Care With Disease Management
$475,265Barbara Daly · Case Western Reserve University · R01 · FY2007 · NR
Defining and characterizing microenvironmental drivers of disseminated tumor cell dormancy in brain
$475,250Cyrus M Ghajar · Fred Hutchinson Cancer Center · R01 · FY2022 · CA
Defining and characterizing microenvironmental drivers of disseminated tumor cell dormancy in brain
$475,250Cyrus M Ghajar · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
Precision Therapy to Target Pancreatic Ductal Adenocarcinoma
$475,248Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA